Elutia (ELUT) Change in Accured Expenses (2019 - 2026)
Elutia (ELUT) reported Change in Accured Expenses of $542000.0 for Q1 2026, up 340.89% on a YoY basis from $122933.5 in Q1 2025, and up 105.5% sequentially from -$9.9 million in Q4 2025.
Elutia (ELUT) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Change in Accured Expenses data on file, last reported at $542000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 340.89% year-over-year to $542000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.8 million (down 70.05% YoY), and the FY2025 full-year result was -$6.5 million, down 470.3% from the prior year.
- Change in Accured Expenses rose to $542000.0 in Q1 2026, from -$9.9 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q3 2022 to a low of -$9.9 million in Q4 2025.
- A 5-year average of -$256352.9 and a median of $409000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 1081.55% in 2025, while the deepest fall reached 5909.15% in 2025.
- Tracing ELUT's Change in Accured Expenses over 5 years: stood at $879000.0 in 2022, then sank by 631.85% to -$4.7 million in 2023, then surged by 96.49% to -$164000.0 in 2024, then sank by 5909.15% to -$9.9 million in 2025, then surged by 105.5% to $542000.0 in 2026.
- Business Quant data shows ELUT's Change in Accured Expenses at $542000.0 in Q1 2026, -$9.9 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 542,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 542,000.00 |
| Mar 31, 2026 | 542,000.00 |
| Dec 31, 2025 | -9.86 Mn |
| Dec 31, 2025 | -9.86 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | -225,000.00 |
| Mar 31, 2025 | -225,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -233,000.00 |
| Sep 30, 2024 | -233,000.00 |
| Jun 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | -4.68 Mn |
| Dec 31, 2023 | -4.68 Mn |